Novo Nordisk As Stock Performance

Novo Nordisk Relative Risk vs. Return Landscape

If you would invest  4,817  in Novo Nordisk AS on November 14, 2025 and sell it today you would earn a total of  58.00  from holding Novo Nordisk AS or generate 1.2% return on investment over 90 days. Novo Nordisk AS is currently producing 0.1083% returns and takes up 4.2025% volatility of returns over 90 trading days. Put another way, 37% of traded pink sheets are less volatile than Novo, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.Assuming the 90 days horizon Novo Nordisk is expected to generate 5.44 times more return on investment than the market. However, the company is 5.44 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.14 per unit of risk.

Novo Nordisk Target Price Odds to finish over Current Price

Assuming the 90 days horizon the pink sheet has the beta coefficient of 1.46 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Novo Nordisk will likely underperform. Additionally Novo Nordisk AS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Novo Nordisk

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Novo Nordisk AS. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 44.55 48.75 52.95 Details

Intrinsic Valuation Low Real High 38.92 43.12 53.63 Details

Novo Nordisk Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Novo Nordisk is not an exception. The market had few large corrections towards the Novo Nordisk's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Novo Nordisk AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Novo Nordisk within the framework of very fundamental risk indicators.

Novo Nordisk Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Novo Nordisk for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Novo Nordisk AS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Novo Nordisk Fundamentals Growth

When running Novo Nordisk's price analysis, check to measure Novo Nordisk's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Nordisk is operating at the current time. Most of Novo Nordisk's value examination focuses on studying past and present price action to predict the probability of Novo Nordisk's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Nordisk's price. Additionally, you may evaluate how the addition of Novo Nordisk to your portfolios can decrease your overall portfolio volatility.